Lexaria granted three US patents for DehydraTECH in hypertension and nicotine delivery

Lexaria Bioscience Corp.

Issued US Patents #11,666,543 and #11,666,544 for DehydraTECH in treating hypertension.
Issued US Patent #11,700,875 covering sublingual nicotine delivery via DehydraTECH.
Plans to file FDA IND for DehydraTECH-CBD for hypertension soon.
Ongoing study NIC-H22-1 tests DehydraTECH nicotine pouches vs commercial alternatives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.